Clobetasol propionate and Xolair drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clobetasol propionate (clobetasol propionate) and Xolair (omalizumab). Common drug interactions include joint swelling among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Clobetasol propionate and Xolair. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Clobetasol propionate?

Clobetasol propionate has active ingredients of clobetasol propionate. It is often used in psoriasis. eHealthMe is studying from 10,661 Clobetasol propionate users. Check the latest studies of Clobetasol propionate.

What is Xolair?

Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 77,554 Xolair users. Check the latest studies of Xolair.

On Jul, 08, 2026

54 people who take Clobetasol propionate and Xolair together, and have interactions are studied.

Clobetasol propionate and Xolair drug interactions.

What are the common drug interactions of Clobetasol Propionate and Xolair, by gender? *:

female:

Joint swelling
Memory impairment
Neuralgia (pain in one or more nerves)
Pain in extremity
Retching (strong involuntary effort to vomit)
Sinusitis (inflammation of sinus)
Skin hypertrophy (skin cells enlarges)
Skin mass
Spinal pain (pain in spine)
Abdominal pain

male:

Weight decreased
Alanine aminotransferase increased
Gait disturbance
Glossitis (infection of tongue with soreness)
Glossodynia (a burning or painful sensation in the tongue)
Inflammation
Mastication disorder (disease of chewing food)
Nausea (feeling of having an urge to vomit)
Oral discomfort (pain or irritation in mouth)
Oral pain

What are the common drug interactions of Clobetasol Propionate and Xolair, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Injection site pain
Injection site swelling

20-29:

n/a

30-39:

Injection related reaction
Maternal exposure during pregnancy (use of substance during pregnancy)

40-49:

Urticaria (rash of round, red welts on the skin that itch intensely)
Blood pressure increased
Malaise (a feeling of general discomfort or uneasiness)
Pruritus (severe itching of the skin)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Dyspnoea (difficult or laboured respiration)
Intervertebral disc protrusion (spinal disc protrusion)
Arthropathy

50-59:

Anaphylactic reaction (serious allergic reaction)
Headache (pain in head)
Angioedema (rapid swelling of the dermis)
Dry eye (lack of adequate tears)
Dry mouth
Foreign body sensation in eyes (feeling of something in eye)
Iridocyclitis (inflammation of the iris and ciliary body of the eye)
Lip swelling
Speech disorder
Throat tightness

60+:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Procedural complication
Abdominal distension
Abdominal pain
Asthenia (weakness)
Chest discomfort
Chills (felling of cold)
Circulatory collapse
Decreased appetite
Diarrhoea

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 9 people, 16.67%
Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 9.26%
Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 4 people, 7.41%
Idiopathic Urticaria (allergic reactions, presence of hives with unknown cause): 4 people, 7.41%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 7.41%
Hypersensitivity: 3 people, 5.56%
High Blood Pressure: 3 people, 5.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.56%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Clobetasol propionate and Xolair?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously